A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung can

Carcinogenesis

Volumn 30, Issue 7, 2009, Pages 1186-1192

  Landvik, Nina E ^a   Hart, Kent ^a   Skaug, Vidar ^a   Stangeland, Lodve B ^b   Haugen, Aage ^a   Zienolddiny, Shanbeh ^a  

^a NATIONAL INSTITUTE OF OCCUPATIONAL HEALTH   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; MESSENGER RNA; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR YIN YANG 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PROTEIN PROTEIN INTERACTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; ENHANCER ELEMENTS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-1BETA; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; RNA, MESSENGER;

EID: 67650221290     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp122     Document Type: Article

References (53)

1. Osada,H. et al. (2002) Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene, 21, 7421-7434.
2. Coussens,L.M. et al. (2002) Inflammation and cancer. Nature, 420, 860-867.
3. Frostad,A. et al. (2008) Impact of respiratory symptoms on lung cancer: 30-year follow-up of an urban population. Lung Cancer, 60, 22-30.
4. Peebles,K.A. et al. (2007) Inflammation and lung carcinogenesis: applying findings in prevention and treatment. Expert Rev. Anticancer Ther., 7, 1405-1421.
5. Skillrud,D.M. et al. (1986) Higher risk of lung cancer in chronic obstructive pulmonary disease. A prospective, matched, controlled study. Ann. Intern. Med., 105, 503-507.
6. Ballaz,S. et al. (2003) The potential contributions of chronic inflammation to lung carcinogenesis. Clin. Lung Cancer, 5, 46-62.
7. Smith,C.J. et al. (2006) Perspectives on pulmonary inflammation and lung cancer risk in cigarette smokers. Inhal. Toxicol., 18 667-677.
8. Dinarello,C.A. (1996) Biologic basis for interleukin-1 in disease. Blood, 87, 2095-2147.
9. Apte,R.N. et al. (2006) The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions. Cancer Metastasis Rev., 25, 387-408.
10. Apte,R.N. et al. (2008) Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol. Rev., 222, 222-241.
11. Saijo,Y. et al. (2002) Proinflammatory cytokine IL-1 beta promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J. Immunol., 169, 469-475.
12. Song,X. et al. (2003) Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. J. Immunol., 171, 6448-6456.
13. Voronov,E. et al. (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl Acad. Sci. USA, 100, 2645-2650.
14. Auron,P.E. et al. (1994) Interleukin-1: A gene expression system regulated at multiple levels. Eur. Cytokine Netw., 5, 573-592.
15. Rogus,J. et al. (2008) IL1B gene promoter haplotype pairs predict clinical levels of interleukin-1beta and C-reactive protein. Hum. Genet., 123, 387-398.
16. Chen,H. et al. (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum. Mol. Genet., 15, 519-529.
17. Park,J.H. et al. (2008) The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominance. Chem. Res. Toxicol., 21, 1039-1049.
18. Shen,Y.M. et al. (2006) Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: Role of reactive oxygen and biological selection. Chem. Res. Toxicol., 19, 1441-1450.
19. Hussain,S.P. et al. (2007) Inflammation and cancer: An ancient link with novel potentials. Int. J. Cancer, 121, 2373-2380.
20. Hussain,S.P. et al. (2000) Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases. Proc. Natl Acad. Sci. USA, 97, 12770-12775.
21. Jaiswal,M. et al. (2001) Nitric oxide in gastrointestinal epithelial cell carcinogenesis: Linking inflammation to oncogenesis. Am. J. Physiol. Gastrointest. Liver Physiol., 281, G626-G634.
22. Zienolddiny,S. et al. (2004) Polymorphisms of the interleukin-1 beta gene are associated with increased risk of non-small cell lung cancer. Int. J. Cancer, 109, 353-356.
23. Tockman,M.S. et al. (1987) Airways obstruction and the risk for lung cancer. Ann. Intern. Med., 106, 512-518.
24. Engels,E.A. et al. (2007) Systematic evaluation of genetic variants in the inflammation pathway and risk of lung cancer. Cancer Res., 67, 6520-6527.
25. Lee,K.A. et al. (2004) Novel interleukin 1beta polymorphism increased the risk of gastric cancer in a Korean population. J. Gastroenterol., 39, 429-433.
26. Berger,P. et al. (2002) C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine, 17, 171-174.
27. Stephens,M. et al. (2003) A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet., 73, 1162-1169.
28. Stephens,M. et al. (2001) A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet., 68, 978-989.
29. Cox,D.G. et al. (2001) Genotype transposer: Automated genotype manipulation for linkage disequilibrium analysis. Bioinformatics., 17, 738-739.
30. Berge,G. et al. (2004) Role of estrogen receptor in regulation of polycyclic aromatic hydrocarbon metabolic activation in lung. Lung Cancer, 45, 289-297.
31. Skaug,V. et al. (2000) p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients. Clin. Cancer Res., 6, 1031-1037.
32. Kristensen,A.T. et al. (2002) Detection of mutations in exon 8 of TP53 by temperature gradient 96-capillary array electrophoresis. Biotechniques, 33, 650-653.
33. Kringen,P. et al. (2005) Evaluation of arrayed primer extension for TP53 mutation detection in breast and ovarian carcinomas. Biotechniques, 39, 755-761.
34. Farre,D. et al. (2003) Identification of patterns in biological sequences at the ALGGEN server: PROMO and MALGEN. Nucleic Acids Res. 31, 3651-3653.
35. Messeguer,X. et al. (2002) PROMO: Detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18, 333-334.
36. Zaykin,D.V. et al. (2006) Contrasting linkage-disequilibrium patterns between cases and controls as a novel association-mapping method. Am. J. Hum. Genet., 78, 737-746.
37. Kulle,B. et al. (2008) Accounting for haplotype phase uncertainty in linkage disequilibrium estimation. Genet. Epidemiol., 32, 168-178.
38. Wacholder,S. et al. (2004) Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J. Natl Cancer Inst., 96, 434-442.
39. Wakefield,J. (2007) A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am. J. Hum. Genet., 81, 208-227.
40. Zienolddiny,S. et al. (2008) A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis, 29, 1164-1169.
41. Krelin,Y. et al. (2007) Interleukin-1beta-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res., 67, 1062-1071.
42. Lee,J.M. et al. (2008) Polymorphisms in interleukin-1B and its receptor antagonist genes and the risk of chronic obstructive pulmonary disease in a Korean population: A case-control study. Respir. Med. 102, 1311-1320.
43. Ter-Minassian,M. et al. (2008) Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. Carcinogenesis 29, 2147-2152.
44. Goodman,J.E. et al. (2004) Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ. Mol. Mutagen., 44, 3-9.
45. Shibata,A. et al. (2002) CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis, 23, 419-424.
46. Pfeifer,G.P. et al. (2002) Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene, 21 7435-7451.
47. Lind,H. et al. (2007) Differential binding of proteins to the IL1B -31 T/C polymorphism in lung epithelial cells. Cytokine, 38, 43-48.
48. El-Omar,E.M. et al. (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature, 404, 398-402.
49. Gordon,S. et al. (2006) Transcription factor YY1: Structure, function, and therapeutic implications in cancer biology. Oncogene 25, 1125-1142.
50. Tsukada,J. et al. (1994) Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1 beta gene. Mol. Cell. Biol., 14, 7285-7297.
51. Choy,L. et al. (2003) Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/ enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J. Biol. Chem., 278, 9609-9619.
52. Wen,Y.D. et al. (2003) Histone deacetylase 3 binds to and regulates the multifunctional transcription factor TFII-I. J. Biol. Chem., 278, 1841-1847.
53. Yordy,J.S. et al. (2000) Signal transduction and the Ets family of transcription factors. Oncogene, 19, 6503-6513.